![]() Twentyeight-Seven Therapeutics Twentyeight-Seven Therapeutics is a biotechnology company focused on the modulation of non-coding RNA (ncRNA) function to treat cancer and other human diseases. | ![]() Pinteon Therapeutics Pinteon Therapeutics is a company that develops cancer therapeutics drugs intended to cure cis-trans isomerase. | ![]() Ayala Pharmaceuticals Ayala Pharmaceuticals is a clinical-stage biopharmaceutical company developing medicines for cancers that are genetically defined. | ![]() NKT Therapeutics NKT Therapeutics is a biotech company developing therapeutics based on immune cells called natural killer T (“NKT”) cells. | ![]() Storm Therapeutics Storm Therapeutics discovers and develops small molecule drugs that target RNA-modifying enzymes, for treatment of cancer. | |
Founding Date | Founding Date 2016 | Founding Date 2014 | Founding Date 2017 | Founding Date 2008 | Founding Date 2015 |
Type | Type Private | Type Private | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Watertown, US HQ | Locations HQ | Locations Wilmington, US HQ Rehovot, IL Wilmington, US | Locations Sharon, US HQ | Locations Cambridge, GB HQ Greater London, GB |
Employees | Employees 6 | Employees 4 | Employees 29 | Employees 4 | Employees 327% increase |
Funding | |||||
Latest funding round | Latest funding round $ 15m (about 7 years ago) | Latest funding round $ 17m (over 6 years ago) | Latest funding round N/A | Latest funding round $ 4m (over 15 years ago) | Latest funding round $ 5.4m (over 8 years ago) |
Total funding raised | Total funding raised $ 80m | Total funding raised $ 20.5m | Total funding raised $ 47m | Total funding raised $ 12m | Total funding raised $ 21.4m |

Pinteon Therapeutics is a company that develops cancer therapeutics drugs intended to cure cis-trans isomerase.
View company
Ayala Pharmaceuticals is a clinical-stage biopharmaceutical company developing medicines for cancers that are genetically defined.
View company
NKT Therapeutics is a biotech company developing therapeutics based on immune cells called natural killer T (“NKT”) cells.
View company
Storm Therapeutics discovers and develops small molecule drugs that target RNA-modifying enzymes, for treatment of cancer.
View company